Stock Events

Medpace 

M$6,890
115
+M$0+0% Friday 15:19

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
133.17B
P/E Ratio
33.63
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21OctExpected
Q1 2024
Q2 2024
Next
42.22
46.62
51.02
55.42
Expected EPS
55.4189644851
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MEDP.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Employees
5000
Country
United States
ISIN
US58506Q1094

Listings